GRM4
Metabotropic glutamate receptor 4
Also known as: GPRC1D, GRM4_HUMAN, mGlu4, MGLUR4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14833
- Gene
- GRM4
- Ensembl
- ENSG00000124493
- Chromosome
- 6
- Canonical length
- 912 aa
- Protein class
- G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
912 residues, UniProt reviewed canonical sequence.
>Q14833|GRM4
1 MPGKRGLGWW WARLPLCLLL SLYGPWMPSS LGKPKGHPHM NSIRIDGDIT LGGLFPVHGR
61 GSEGKPCGEL KKEKGIHRLE AMLFALDRIN NDPDLLPNIT LGARILDTCS RDTHALEQSL
121 TFVQALIEKD GTEVRCGSGG PPIITKPERV VGVIGASGSS VSIMVANILR LFKIPQISYA
181 STAPDLSDNS RYDFFSRVVP SDTYQAQAMV DIVRALKWNY VSTVASEGSY GESGVEAFIQ
241 KSREDGGVCI AQSVKIPREP KAGEFDKIIR RLLETSNARA VIIFANEDDI RRVLEAARRA
301 NQTGHFFWMG SDSWGSKIAP VLHLEEVAEG AVTILPKRMS VRGFDRYFSS RTLDNNRRNI
361 WFAEFWEDNF HCKLSRHALK KGSHVKKCTN RERIGQDSAY EQEGKVQFVI DAVYAMGHAL
421 HAMHRDLCPG RVGLCPRMDP VDGTQLLKYI RNVNFSGIAG NPVTFNENGD APGRYDIYQY
481 QLRNDSAEYK VIGSWTDHLH LRIERMHWPG SGQQLPRSIC SLPCQPGERK KTVKGMPCCW
541 HCEPCTGYQY QVDRYTCKTC PYDMRPTENR TGCRPIPIIK LEWGSPWAVL PLFLAVVGIA
601 ATLFVVITFV RYNDTPIVKA SGRELSYVLL AGIFLCYATT FLMIAEPDLG TCSLRRIFLG
661 LGMSISYAAL LTKTNRIYRI FEQGKRSVSA PRFISPASQL AITFSLISLQ LLGICVWFVV
721 DPSHSVVDFQ DQRTLDPRFA RGVLKCDISD LSLICLLGYS MLLMVTCTVY AIKTRGVPET
781 FNEAKPIGFT MYTTCIVWLA FIPIFFGTSQ SADKLYIQTT TLTVSVSLSA SVSLGMLYMP
841 KVYIILFHPE QNVPKRKRSL KAVVTAATMS NKFTQKGNFR PNGEAKSELC ENLEAPALAT
901 KQTYVTYTNH AILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRM4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 254 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 254 nTPM
- basal ganglia: 17 nTPM
- spinal cord: 4.1 nTPM
- hypothalamus: 3.3 nTPM
- cerebral cortex: 2.8 nTPM
- hippocampal formation: 1.9 nTPM
Single-cell type
- brain excitatory neurons: 164 nCPM
- retinal amacrine cells: 74 nCPM
- pancreatic islet cells: 48 nCPM
- brain inhibitory neurons: 44 nCPM
- retinal ganglion cells: 39 nCPM
- somatotrophs: 19 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 172 nTPM
- basal ganglia: 26 nTPM
- thalamus: 17 nTPM
- pons: 14 nTPM
- cerebral cortex: 12 nTPM
- midbrain: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 2.68
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway
- chemical synaptic transmission
- G protein-coupled glutamate receptor signaling pathway
- neurotransmitter secretion
- positive regulation of MAPK cascade
- regulation of neuron apoptotic process
- regulation of synaptic transmission, glutamatergic
Molecular functions
- adenylate cyclase inhibiting G protein-coupled glutamate receptor activity
- G protein-coupled receptor activity
- glutamate receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPCR, family 3, metabotropic glutamate receptor
- GPCR, family 3
- Receptor, ligand binding region
- GPCR, family 3, nine cysteines domain
- GPCR family 3, C-terminal
- GPCR, family 3, conserved site
- Periplasmic binding protein-like I
- GPCR, family 3, nine cysteines domain superfamily
- Metabotropic Glutamate Receptor
- 7 transmembrane sweet-taste receptor of 3 GCPR
- Receptor family ligand binding region
- Nine Cysteines Domain of family 3 GPCR
- GPCR, family 3, metabotropic glutamate receptor 4
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRM4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRM4 as an antibody target. Whether an autoantibody or antibody against GRM4 could matter depends on whether native GRM4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRM4 is annotated at the cell surface, where native GRM4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRM4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...